Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat and Benzbromarone for Left Ventricle Diastolic Dysfunction
NCT03534037Phase 4Unknown
- Sponsor
- National Defense Medical Center
- Start
- Feb 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of febuxostat in hyperuricemia, left ventricular diastolic dysfunction (LVDD), sponsored by National Defense Medical Center. Status: unknown.
02
Drugs
febuxostat
03
Conditions
hyperuricemialeft ventricular diastolic dysfunction (LVDD)
Beyond the preview
Go deeper on NCT03534037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03534037.